617 related articles for article (PubMed ID: 21417950)
1. Hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis and its safety in pregnancy.
Abarientos C; Sperber K; Shapiro DL; Aronow WS; Chao CP; Ash JY
Expert Opin Drug Saf; 2011 Sep; 10(5):705-14. PubMed ID: 21417950
[TBL] [Abstract][Full Text] [Related]
2. Hydroxychloroquine in systemic lupus erythematosus (SLE).
Ponticelli C; Moroni G
Expert Opin Drug Saf; 2017 Mar; 16(3):411-419. PubMed ID: 27927040
[TBL] [Abstract][Full Text] [Related]
3. Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group.
Costedoat-Chalumeau N; Amoura Z; Duhaut P; Huong DL; Sebbough D; Wechsler B; Vauthier D; Denjoy I; Lupoglazoff JM; Piette JC
Arthritis Rheum; 2003 Nov; 48(11):3207-11. PubMed ID: 14613284
[TBL] [Abstract][Full Text] [Related]
4. Impact of hydroxychloroquine on preterm delivery and intrauterine growth restriction in pregnant women with systemic lupus erythematosus: a descriptive cohort study.
Leroux M; Desveaux C; Parcevaux M; Julliac B; Gouyon JB; Dallay D; Pellegrin JL; Boukerrou M; Blanco P; Lazaro E
Lupus; 2015 Nov; 24(13):1384-91. PubMed ID: 26082465
[TBL] [Abstract][Full Text] [Related]
5. Hydroxychloroquine in lupus pregnancy.
Clowse ME; Magder L; Witter F; Petri M
Arthritis Rheum; 2006 Nov; 54(11):3640-7. PubMed ID: 17075810
[TBL] [Abstract][Full Text] [Related]
6. Safety of hydroxychloroquine in pregnant patients with connective tissue diseases. Review of the literature.
Costedoat-Chalumeau N; Amoura Z; Huong DL; Lechat P; Piette JC
Autoimmun Rev; 2005 Feb; 4(2):111-5. PubMed ID: 15722258
[TBL] [Abstract][Full Text] [Related]
7. The Pharmacological Mechanisms and Therapeutic Activities of Hydroxychloroquine in Rheumatic and Related Diseases.
Hu C; Lu L; Wan JP; Wen C
Curr Med Chem; 2017; 24(20):2241-2249. PubMed ID: 28302011
[TBL] [Abstract][Full Text] [Related]
8. Discontinuation of antimalarial drugs in systemic lupus erythematosus.
Wang C; Fortin PR; Li Y; Panaritis T; Gans M; Esdaile JM
J Rheumatol; 1999 Apr; 26(4):808-15. PubMed ID: 10229401
[TBL] [Abstract][Full Text] [Related]
9. Hydroxychloroquine and lupus pregnancy: review of a series of 36 cases.
Buchanan NM; Toubi E; Khamashta MA; Lima F; Kerslake S; Hughes GR
Ann Rheum Dis; 1996 Jul; 55(7):486-8. PubMed ID: 8774170
[TBL] [Abstract][Full Text] [Related]
10. Myopathy complicating lupus pregnancy.
Priori R; Gattamelata A; d'Amati G; Giordano C; Piccioni MG; Valesini G; Framarino-dei-Malatesta M
J Clin Rheumatol; 2013 Apr; 19(3):132-3. PubMed ID: 23519179
[TBL] [Abstract][Full Text] [Related]
11. Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus.
Wolfe F; Marmor MF
Arthritis Care Res (Hoboken); 2010 Jun; 62(6):775-84. PubMed ID: 20535788
[TBL] [Abstract][Full Text] [Related]
12. The use of hydroxychloroquine in lupus pregnancy: the British experience.
Khamashta MA; Buchanan NM; Hughes GR
Lupus; 1996 Jun; 5 Suppl 1():S65-6. PubMed ID: 8803914
[TBL] [Abstract][Full Text] [Related]
13. [Pleading to maintain hydroxychloroquine throughout Lupus pregnancies].
Costedoat-Chalumeau N; Amoura Z; Le Thi Huong D; Wechsler B; Piette JC
Rev Med Interne; 2005 Jun; 26(6):467-9. PubMed ID: 15936475
[TBL] [Abstract][Full Text] [Related]
14. [The safety of hydroxychloroquine in pregnant patients with systemic lupus erythematosus].
Zhang L; Ma L; Lin B; Wu DH; Wang GC
Zhonghua Nei Ke Za Zhi; 2011 Nov; 50(11):918-21. PubMed ID: 22333122
[TBL] [Abstract][Full Text] [Related]
15. Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.
Rainsford KD; Parke AL; Clifford-Rashotte M; Kean WF
Inflammopharmacology; 2015 Oct; 23(5):231-69. PubMed ID: 26246395
[TBL] [Abstract][Full Text] [Related]
16. Pregnancy outcome following in utero exposure to hydroxychloroquine: a prospective comparative observational study.
Diav-Citrin O; Blyakhman S; Shechtman S; Ornoy A
Reprod Toxicol; 2013 Aug; 39():58-62. PubMed ID: 23602891
[TBL] [Abstract][Full Text] [Related]
17. Hydroxychloroquine prophylaxis for preeclampsia, hypertension and prematurity in pregnant patients with systemic lupus erythematosus: A meta-analysis.
Duan J; Ma D; Wen X; Guo Q; Gao J; Zhang G; Xu K; Zhang L
Lupus; 2021 Jun; 30(7):1163-1174. PubMed ID: 33853420
[TBL] [Abstract][Full Text] [Related]
18. Pregnancy outcome following first trimester exposure to chloroquine.
Levy M; Buskila D; Gladman DD; Urowitz MB; Koren G
Am J Perinatol; 1991 May; 8(3):174-8. PubMed ID: 2029276
[TBL] [Abstract][Full Text] [Related]
19. Reproductive outcomes following hydroxychloroquine use for autoimmune diseases: a systematic review and meta-analysis.
Kaplan YC; Ozsarfati J; Nickel C; Koren G
Br J Clin Pharmacol; 2016 May; 81(5):835-48. PubMed ID: 26700396
[TBL] [Abstract][Full Text] [Related]
20. Hydroxychloroquine in pregnant patients with systemic lupus erythematosus.
Parke A; West B
J Rheumatol; 1996 Oct; 23(10):1715-8. PubMed ID: 8895146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
